SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -75.82 Million USD | -10.26% |
| 2021 | -68.76 Million USD | -34.69% |
| 2020 | -51.05 Million USD | -49.01% |
| 2019 | -34.26 Million USD | -67.93% |
| 2018 | -20.4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -17.1 Million USD | 6.28% |
| 2023 Q1 | -18.25 Million USD | -99.07% |
| 2023 Q3 | -16.11 Million USD | 5.79% |
| 2022 FY | -75.82 Million USD | -10.26% |
| 2022 Q1 | -21.05 Million USD | -77.95% |
| 2022 Q4 | -9.17 Million USD | 60.3% |
| 2022 Q2 | -22.5 Million USD | -6.89% |
| 2022 Q3 | -23.09 Million USD | -2.64% |
| 2021 Q3 | -22.45 Million USD | 0.0% |
| 2021 FY | -68.76 Million USD | -34.69% |
| 2021 Q4 | -11.83 Million USD | 47.31% |
| 2020 FY | -51.05 Million USD | -49.01% |
| 2019 FY | -34.26 Million USD | -67.93% |
| 2018 FY | -20.4 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -5577.942% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -1403.127% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -324.861% |
| Nascent Biotech, Inc. | -2.22 Million USD | -3300.409% |
| Rebus Holdings, Inc. | -664 Thousand USD | -11319.428% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 192.637% |
| Qrons Inc. | -643.67 Thousand USD | -11679.977% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -19363.768% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -36.602% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -18150.02% |
| Skye Bioscience, Inc. | -13.67 Million USD | -454.609% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -5.626% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 1642.786% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -28871.138% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -2560.053% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -4836.366% |
| Mesoblast Limited | -84.14 Million USD | 9.89% |
| Marizyme, Inc. | -34.08 Million USD | -122.449% |
| Genus plc | 6.4 Million USD | 1284.766% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 878.294% |
| Pharming Group N.V. | -4.87 Million USD | -1453.936% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -3717.055% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -8041.145% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -808.084% |
| ContraFect Corporation | -56.88 Million USD | -33.286% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -1564.754% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -5308.38% |
| IMV Inc. | -38.67 Million USD | -96.075% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -2656.432% |
| MultiCell Technologies, Inc. | -722.81 USD | -10490208.656% |
| ONE Bio Corp. | 13.68 Million USD | 654.214% |
| Accustem Sciences Inc. | -3.74 Million USD | -1923.933% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -28.539% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -15596.743% |
| Q BioMed Inc. | -3.44 Million USD | -2100.622% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 2241.949% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -2785.799% |
| Biomind Labs Inc. | -1 Million USD | -7410.378% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -37.933% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -2513.529% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -1040.566% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -3967.058% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -253055.048% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -377.796% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -3823.451% |
| GB Sciences, Inc. | -1.42 Million USD | -5237.875% |
| Alpha Cognition Inc. | -9.7 Million USD | -681.25% |
| HST Global, Inc. | -140.9 Thousand USD | -53712.089% |
| CSL Limited | 3.7 Billion USD | 102.048% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -6640.563% |
| Halberd Corporation | -75.05 Thousand USD | -100932.645% |
| Enzolytics Inc. | -2.14 Million USD | -3428.714% |
| Agentix Corp. | -1.37 Million USD | -5427.587% |
| Resverlogix Corp. | -12.74 Million USD | -494.753% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -2293.259% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 82.161% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -7162.931% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -2497.241% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -4701.011% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -2126.886% |
| AVAX Technologies, Inc. | 6.69 Million USD | 1232.92% |
| Zenith Capital Corp. | -8.94 Million USD | -747.87% |
| Genscript Biotech Corporation | -415.79 Million USD | 81.764% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -435150.56% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -2988.196% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -44110.369% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -3682.254% |
| Kadimastem Ltd | -3.04 Million USD | -2394.038% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -7605.378% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -5937.022% |
| BioStem Technologies, Inc. | -7.77 Million USD | -874.744% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -41680.312% |
| LadRx Corporation | -3.82 Million USD | -1883.065% |
| Cell Source, Inc. | -4.32 Million USD | -1653.039% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -10937.921% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -10937.921% |
| NovAccess Global Inc. | -2.46 Million USD | -2973.87% |
| Affymax, Inc. | -15.04 Million USD | -403.955% |
| Itoco Inc. | -919.14 Thousand USD | -8149.559% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -1688.995% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -6676.139% |
| Mobile Lads Corp. | -554.55 Thousand USD | -13573.249% |
| CytoDyn Inc. | -18.05 Million USD | -319.897% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -301151.49% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -34353.694% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -13326.937% |
| SYBLEU INC | -149.18 Thousand USD | -50727.859% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -4074.65% |
| International Stem Cell Corporation | -663 Thousand USD | -11336.652% |
| Bioxytran, Inc. | -3.82 Million USD | -1884.871% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -143944.453% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -372687.611% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -109.08% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -4586.341% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -10204.62% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -2337.319% |
| Neutra Corp. | -229.48 Thousand USD | -32941.231% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -332.322% |
| PureTech Health plc | -146.19 Million USD | 48.136% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -252.82% |
| IXICO plc | -1.43 Million USD | -5176.618% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -698.915% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 37.749% |
| CSL Limited | 3.81 Billion USD | 101.989% |
| Cellectis S.A. | -108.85 Million USD | 30.345% |